JP2023546361A5 - - Google Patents
Info
- Publication number
- JP2023546361A5 JP2023546361A5 JP2023521356A JP2023521356A JP2023546361A5 JP 2023546361 A5 JP2023546361 A5 JP 2023546361A5 JP 2023521356 A JP2023521356 A JP 2023521356A JP 2023521356 A JP2023521356 A JP 2023521356A JP 2023546361 A5 JP2023546361 A5 JP 2023546361A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063089355P | 2020-10-08 | 2020-10-08 | |
| US63/089,355 | 2020-10-08 | ||
| US202163178748P | 2021-04-23 | 2021-04-23 | |
| US63/178,748 | 2021-04-23 | ||
| PCT/EP2021/077702 WO2022074123A1 (en) | 2020-10-08 | 2021-10-07 | Treatment of flares in lupus |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023546361A JP2023546361A (ja) | 2023-11-02 |
| JPWO2022074123A5 JPWO2022074123A5 (https=) | 2024-09-24 |
| JP2023546361A5 true JP2023546361A5 (https=) | 2024-09-24 |
Family
ID=78269610
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023521356A Pending JP2023546361A (ja) | 2020-10-08 | 2021-10-07 | ループスにおける紅斑の治療 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240026015A1 (https=) |
| EP (1) | EP4225791A1 (https=) |
| JP (1) | JP2023546361A (https=) |
| KR (1) | KR20230082659A (https=) |
| CN (1) | CN116406296A (https=) |
| AU (1) | AU2021356122B2 (https=) |
| BR (1) | BR112023006328A2 (https=) |
| CA (1) | CA3197055A1 (https=) |
| IL (1) | IL301759A (https=) |
| TW (1) | TW202237647A (https=) |
| WO (1) | WO2022074123A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP20231255T1 (hr) | 2021-04-23 | 2024-02-02 | Astrazeneca Ab | Režim doziranja anti-ifnar1 za potkožnu injekciju |
| BR112023021868A2 (pt) * | 2021-04-23 | 2023-12-19 | Astrazeneca Ab | Tratamento de lúpus eritematoso cutâneo |
| EP4587005A1 (en) | 2022-09-14 | 2025-07-23 | Viatris Asia Pacific Pte. Ltd. | Sip 1 receptor modulators for use in the treatment of type 1 ifn mediated diseases |
| EP4545090A1 (en) * | 2023-10-27 | 2025-04-30 | Universität Leipzig | Interferon-a receptor immune modulator for use as a medicament |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUE035082T2 (en) | 2004-06-21 | 2018-05-02 | Squibb & Sons Llc | Interferon alpha receptor 1 antibodies and their use |
| EP2687232A1 (en) * | 2006-12-06 | 2014-01-22 | MedImmune, LLC | Methods of treating systemic lupus erythematosus |
| HRP20160855T1 (hr) | 2008-02-08 | 2016-09-23 | Medimmune, Llc | Anti-ifnar1 protutijela sa smanjenim afinitetom fc liganda |
| US20120251546A1 (en) | 2009-09-03 | 2012-10-04 | Medimmune Llc | Type 1 inteferon diagnostic |
| CA2995222C (en) | 2015-08-19 | 2021-07-13 | Medimmune, Llc | Stable anti-ifnar1 formulation |
| CN106243226B (zh) * | 2016-08-05 | 2019-02-12 | 北京智仁美博生物科技有限公司 | 抗人ifnar1的抗体及其用途 |
| KR102766960B1 (ko) * | 2019-11-11 | 2025-02-11 | 아스트라제네카 아베 | 전신성 홍반성 루푸스에서 i형 인터페론 억제 |
| CN115667309A (zh) * | 2020-05-29 | 2023-01-31 | 阿斯利康(瑞典)有限公司 | 使用i型干扰素信号传导的抑制剂治疗心血管代谢疾病 |
-
2021
- 2021-10-06 TW TW110137117A patent/TW202237647A/zh unknown
- 2021-10-07 US US18/248,280 patent/US20240026015A1/en active Pending
- 2021-10-07 KR KR1020237015211A patent/KR20230082659A/ko active Pending
- 2021-10-07 WO PCT/EP2021/077702 patent/WO2022074123A1/en not_active Ceased
- 2021-10-07 AU AU2021356122A patent/AU2021356122B2/en active Active
- 2021-10-07 CA CA3197055A patent/CA3197055A1/en active Pending
- 2021-10-07 BR BR112023006328A patent/BR112023006328A2/pt unknown
- 2021-10-07 JP JP2023521356A patent/JP2023546361A/ja active Pending
- 2021-10-07 EP EP21794319.0A patent/EP4225791A1/en active Pending
- 2021-10-07 IL IL301759A patent/IL301759A/en unknown
- 2021-10-07 CN CN202180068143.4A patent/CN116406296A/zh active Pending